<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04522388</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00228299</org_study_id>
    <nct_id>NCT04522388</nct_id>
  </id_info>
  <brief_title>Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant</brief_title>
  <official_title>A Pilot Study Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This non-randomized pilot study aims to investigate whether a protein rich nutritional shake&#xD;
      (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured&#xD;
      by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index).&#xD;
      A nutritional supplement would be a cost-effective solution to treat malnutrition, a known&#xD;
      risk factor implicated in poor outcomes for lung transplant recipients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 1, 2022</start_date>
  <completion_date type="Anticipated">March 30, 2024</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Ensure Enlive, Nutritional shake, twice a day</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of nutritional supplementation on skeletal muscle mass as assessed by ultrasound of the quadriceps</measure>
    <time_frame>Pre-transplant</time_frame>
    <description>To examine the effect of nutritional supplementation on skeletal muscle mass in patients with end stage lung disease who are awaiting lung transplant, measured by ultrasound of the quadriceps.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effect of nutritional supplementation on Nutritional Risk index as assessed by serum albumin level</measure>
    <time_frame>Pre-transplant</time_frame>
    <description>To examine the effect of nutritional supplementation on Nutritional Risk index, measured by serum albumin level.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Lung Transplant; Complications</condition>
  <arm_group>
    <arm_group_label>Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nutritional shakes, Ensure Enlive, twice per day orally in patients awaiting lung transplant</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ensure Enlive</intervention_name>
    <description>Ensure Enlive shake twice a day</description>
    <arm_group_label>Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects 18 years or older who are listed for single or double lung transplant&#xD;
&#xD;
          -  Subject provides written informed consent to participate in this study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject with history of Galactosemia&#xD;
&#xD;
          -  Subject with history of milk protein allergy&#xD;
&#xD;
          -  Subject with history of soy protein allergy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Errol Bush, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Errol Bush, MD</last_name>
    <phone>410-614-3891</phone>
    <email>errol.bush@jhu.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Judi Willhide, RN</last_name>
    <phone>410-955-3597</phone>
    <email>jwillhi3@jhmi.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/30447192</url>
    <description>Sarcopenia of the Psoas Muscles Is Associated With Poor Outcomes Following Lung Transplantation</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/23664761</url>
    <description>Impact of nutritional state on lung transplant outcomes</description>
  </link>
  <reference>
    <citation>Hsu J, Krishnan A, Lin CT, Shah PD, Broderick SR, Higgins RSD, Merlo CA, Bush EL. Sarcopenia of the Psoas Muscles Is Associated With Poor Outcomes Following Lung Transplantation. Ann Thorac Surg. 2019 Apr;107(4):1082-1088. doi: 10.1016/j.athoracsur.2018.10.006. Epub 2018 Nov 14.</citation>
    <PMID>30447192</PMID>
  </reference>
  <reference>
    <citation>Chamogeorgakis T, Mason DP, Murthy SC, Thuita L, Raymond DP, Pettersson GB, Blackstone EH. Impact of nutritional state on lung transplant outcomes. J Heart Lung Transplant. 2013 Jul;32(7):693-700. doi: 10.1016/j.healun.2013.04.005. Epub 2013 May 9.</citation>
    <PMID>23664761</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 18, 2020</study_first_submitted>
  <study_first_submitted_qc>August 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2020</study_first_posted>
  <last_update_submitted>August 4, 2021</last_update_submitted>
  <last_update_submitted_qc>August 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pre-hab</keyword>
  <keyword>nutrition</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data sharing will be</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data will be available upon completion of the study analysis</ipd_time_frame>
    <ipd_access_criteria>Upon request to principal investigator</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

